BRCA1 and breast cancer: Evidence showed that pathogenic mutations in non-BRCA HRR genes could also help identify susceptibility to familial breast cancer and showed PARPi sensitivity similar to BRCA1/2 (Mirza et al., 2016; Castroviejo-Bermejo et al., 2018).